Early-stage
China's InventisBio secures $147m Series D
GL Ventures, the China venture capital arm of Hillhouse Capital, has led a $147 million Series D round for Shanghai-based biotech developer InventisBio.
China robotics player Cyclone gets $40m Series B
Matrix Partners China has led a $40 million Series B round for local robotics start-up Cyclone. Other investors include DCM, Lenovo Capital, Source Code Capital, and Renzhi Capital.
Japan gaming start-up raises Series A, hits $1b valuation
Playco, a Japan-headquartered mobile gaming start-up, has simultaneously formally launched operations and become a unicorn, raising $100 million in Series A funding at a valuation of $1 billion.
Deal focus: Airmeet rewires the conference circuit
As social distancing and travel restrictions play havoc with traditional conferences, Airmeet has seen a spike in demand for its virtual alternatives. A Series A round duly followed
Rise Fund, Swire back Asia plant-based food specialist
The Rise Fund, TPG’s impact investment vehicle, and Hong Kong conglomerate Swire Pacific have led a $70 million round for Green Monday Holdings, a Hong Kong plant-based protein provider.
Deal focus: Waresix builds Indonesia’s logistical lynchpin
Jungle Ventures and EV Growth lead $75 million round for Waresix, backing the company's integrated platform as a solution to Indonesia's logistics challenges
China drug developer Sumgen raises $32m
Addor Capital has led a RMB220 million ($32 million) Series B funding round for Hangzhou-based drug developer Sumgen Biotech.
Panacea leads $40m Series C for China's XWPharma
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Long Hill invests $30m in Chinese O2O pharmacy player
Chinese digital healthcare platform inCarey has raised $30 million in an extended tranche of Series B funding from Long Hill Capital.
Asia-focused events platform Airmeet raises $12m
Sequoia Capital India has led a $12 million Series A round for US-based and Asia-focused virtual events platform provider Airmeet.
GL Ventures leads $58m Series B in China’s GemPharmatech
GemPharmatech, a Chinese company that provides genetically-modified mice for use in drug tests, has raised RMB400 million ($58.6 million) Series B led by GL Ventures, the VC arm of Hillhouse Capital.
China fresh produce retail: Changing channels
From online grocers to group buying platforms, capital is pouring into China’s fresh produce space as e-commerce finally makes it mark. Which business model will prevail?
Q&A: Starquest Capital's Frankie Fang
Frankie Fang, founding managing partner of China-focused fund-of-funds Starquest Capital, discusses early-stage valuations, specialization among domestic managers, and renminbi fundraising
China autonomous driving: Dimension jump
There are no arguments about the transformational potential of autonomous driving in China, but investors have different ideas about where to find value
EV Growth, Jungle lead round for Indonesia's Waresix
Indonesian logistics technology provider Waresix has secured about $75 million in Series B funding led by existing backers EV Growth and Jungle Ventures.
Korean AI drug developer secures $14m Series B
Oncocross, a South Korean drug developer that uses artificial intelligence (AI) to identify new applications for treatments already in clinical trials, has raised KRW16.5 billion ($14 million) in Series B funding led by Smilegate Investment and GNTech...
China apps going global: Empires on hold
China’s data-driven consumer apps are having a harder time keeping politics out of business as they become increasingly competitive in global markets. Lessons are plentiful; solutions are not
Africa-focused GP leads Series B for Singapore's Thunes
Africa-focused private equity firm Helios Investment Partners has led a $60 million Series B round for Singapore financial technology start-up Thunes.
Deal focus: Putting Asia on the air mobility map
Japan’s SkyDrive leads Asia in the niche but potentially society-altering category of flying cars. A $37 million Series B round marks the latest step in a long safety build-out and public acceptance process
China biotech player InxMed raises $19m
Ennovation Ventures, a Chinese life sciences and healthcare-focused investor, and China Growth Capital have led a RMB130 million ($19 million) round for local biotech developer InxMed.
China mixed reality player Nreal secures $40m Series B
Nreal, a Chinese manufacturers of advanced virtual reality glasses that resemble normal sunglasses, has raised $40 million in Series B funding led by local video sharing platform Kuaishou.
Chinese cleaning robot developer gets $22m Series B
Gaussian Robotics, a China-based developer of robots used for cleaning, has raised RMB150 million ($22 million) in an extended tranche of Series B round led by Broad Vision Funds and China Capital Management.
Xiaomi joins $54m Series B for Indonesia's PasarPolis
Chinese electronics maker Xiaomi has joined a $54 million Series B round for Indonesian financial technology provider PasarPolis.
Sequoia leads Series B for Chinese coffee brand
Saturnbird, a Chinese coffee brand, has raised more than RMB100 million（$14 million) in a Series B funding round led by Sequoia Capital China. Existing backer Frees Fund re-upped.